Gabelli Healthcare & WellnessRx Trust logo

Gabelli Healthcare & WellnessRx Trust(GRX)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL RECENCY
2-STAR RATING
Consider higher Upturn Star rating
BUY for 19 days
PROFIT SINCE LAST BUY
+3.58% ▲
LAST CLOSE
$10.41
11/13/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for GRX

11/13/2026: GRX (2-star) has a low Upturn Star Rating. Not recommended to BUY.

Gabelli Healthcare & WellnessRx Trust is a non-diversified, closed-end investment fund that provides investors with active exposure to the healthcare and wellness sectors. Its primary strength lies in the management team's research-intensive approach, which targets undervalued companies with long-term growth potential. The main investment story centers on capturing value from advancements in biotechnology, digital health, and wellness consumer trends. However, investors must consider risks such as potential NAV discounts, sector-specific regulatory pressures, and competition from lower-cost passive alternatives. This stock may suit value-oriented investors seeking consistent distributions, provided they monitor the fund's discount levels and the performance of the underlying healthcare equity holdings.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorMixed fitThe fund focuses on long-term capital appreciation, though active management introduces performance variance.
Momentum investorWeak fitThis is a fundamental-based, long-term vehicle, not suited for short-term momentum strategies.
Value investorStrong fitThe Gabelli investment philosophy is rooted in finding undervalued companies, which aligns with value-oriented strategies.
Dividend investorStrong fitThe fund provides consistent distributions, making it suitable for income-seeking investors.
Low-risk investorWeak fitEquity market exposure and the potential use of leverage make this unsuitable for low-risk, capital preservation goals.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityMedium / highAs an equity-focused fund, share price and NAV can fluctuate significantly with market sentiment.
Valuation riskMediumThe fund can trade at a discount or premium to NAV, affecting investor entry and exit points.
Competition risk (sector ETF competition)MediumLow-cost passive alternatives continue to attract assets away from actively managed closed-end funds.
Business qualityMediumThe fund's performance is tied to the quality of the individual healthcare and wellness stocks selected.
Dividend incomeMediumDistributions are dependent on underlying portfolio performance and may not always be sustainable.
Execution riskMediumThe investment team's ability to pick winners in the volatile healthcare sector is critical to long-term success.

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 151.41M USD
Price to earnings Ratio 18.26
1Y Target Price -
Price to earnings Ratio 18.26
1Y Target Price -
Volume (30-day avg) 18.2K shares
Beta -
52 Weeks Range 8.54 - 10.64
Updated Date 11/14/2026
52 Weeks Range 8.54 - 10.64
Updated Date 11/14/2026
Dividends yield (FY) -
Basic EPS (TTM) 0.57

Sector & Industry Intelligence

Sector

Financial Services

Constructive
Sentiment
Bullish
Momentum
BUY Breadth Improving
BUY participation
50.4%
Active BUY / eligible
61 / 121
30-Day BUY Count Change
+45
Market state
Bullish

More qualifying stocks are receiving or maintaining BUY advisories, indicating improving market participation.

Industry

Asset Management

BUY participation
52.9%
Active BUY / eligible
9 / 17
30-Day BUY Count Change
+3

Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.

Price Behavior

Strong Uptrend
PRICE PATH

Strong Uptrend

The stock has maintained a strong upward price trend across the last three quarters.

Very Smooth
PRICE STABILITY

Very Smooth

The stock has followed a highly orderly price path with minimal short-term disruption.

Analysis of Past Performance

Type Stock
Historic Profit 21.77%
Avg. Invested days 52
Today’s Advisory Consider higher Upturn Star rating
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 4.0
Stock Returns Performance Upturn Returns Performance icon 3.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/13/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
GRX receives a 3-star rating, supported by strong unit economics, and solid company fundamentals. The rating is constrained by soft analyst coverage, and weak price momentum.

Company Fundamentals

★★★★★
GRX has solid overall fundamentals (4 stars), with solid financial health, solid growth momentum, and moderate ownership. In FY2025 versus FY2024, strong earnings growth (+905.1%) and strong cash generation (FCF margin 61.8%) are partially offset by modest insider ownership of 1.77%.

Financial Health Rating

★★★★★
GRX's financial health is supported by solid cash strength, including free-cash-flow generation (61.8% of revenue). Liquidity is moderate (3 stars), which helps explain the 4-star overall score.

Growth Momentum Score

★★★★★
Earnings growth is GRX's strongest growth driver at +905.1% FY2025 versus FY2024 (strong, 5 stars). By comparison, revenue growth (+368.7%, strong) is also strong, while free-cash-flow growth (-28.0%, negative) holds the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 42.0% (solid) and 0.0% of outstanding shares are publicly tradable (soft). Insider ownership of 1.77% provides only moderate management-shareholder alignment.

Unit Economics (Per $1K Revenue)

★★★★★
GRX generates approximately $837 of gross profit, $310 of operating income, and $618 of free cash flow for every $1,000 of revenue. Based on FY2025 results. Strong margins and strong cash conversion support the rating, although capital efficiency remains weak.

Economic Dimensions

★★★★★
Effective Tax Rate: 0.00%

Quantitative Style Profile

★★★★★
GRX has a relatively low-volatility profile. Weak momentum is the primary drawback, while valuation that is moderately attractive rather than deeply discounted.

Style Classification

Quality Focused

Low VolatilitySmall / Mid Cap Risk

How Company Makes Money

Business areaWhat it includesRetail investor read
Investment PortfolioCapital gains, dividends, and interest from a portfolio of healthcare and wellness equities.The fund generates returns primarily through the stock performance and dividends of the companies it owns.
Geographic ExposureGlobal equity markets with a primary focus on US-listed healthcare and wellness companies.The fund is largely exposed to the US market, which is the hub for much of global healthcare innovation.

Valuation

Trailing PE 18.26
Forward PE -
Enterprise Value -
Price to Sales(TTM) 18.12
Enterprise Value -
Price to Sales(TTM) 18.12
Enterprise Value to Revenue 17.09
Enterprise Value to EBITDA -
Shares Outstanding 14.54M
Shares Floating -
Shares Outstanding 14.54M
Shares Floating -
Percent Insiders 1.77
Percent Institutions 42.02

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.